EasyJet Assures Summer Flight Schedule Unaffected by Jet Fuel Supply Concerns Amid Iran Tensions US Intensifies Efforts to Deploy American AI Across Asia Following TrumpXi Talks Melonis Coalition Triumphs in Venice Mayoral Election Challenging PrePoll Expectations Retail Investors Gain Direct Access to SpaceX IPO via Major Brokerage Platforms Jeremy Granthams Investment Mantra Patience and Value Over Panic in Volatile Markets Medantas Growth Strategy Established Hospitals Anchor NearTerm Performance Expansion Plans Underway Health In Tech Inc HIT Q1 2026 Earnings EPS Meets Estimates Stock Slips 26 Snap Inc SNAP Q1 2026 Earnings Modest EPS Beat Amid Unreported Revenue Figures DGICB Q1 2026 Earnings EPS Misses Estimates Amidst Challenging Underwriting Environment SKWD Q1 2026 Earnings EPS Surges Past Estimates Despite Limited Revenue Disclosure FCNCO Q1 2026 Earnings Preferred Shares Deliver Strong EPS Surprise Amid Steady Underlying Performance PagerDuty Q1 2026 Earnings EPS Beats Estimates by 1499 Stock Climbs 213 MBNKO Preferred Shares Hold Steady Near 2569 Amid Low Volatility Tecnoglass TGLS Surges 333 Testing Key Resistance Zone LogProstyle Inc LGPS Shares Slip 423 as Selling Pressure Tests Key Support at 063 BBB Foods Inc TBBB Slips 124 as Stock Navigates Key Support and Resistance Levels Sonic Automotive SAH Edges Higher as Shares Test Key Levels International Students Face Mounting Barriers to US Employment as Hiring Market Weakens ANIP Q1 2026 Earnings Strong EPS Beat Driven by Operational Execution MIND CTI Ltd MNDO Edges Higher Amid Consolidation Key Levels to Watch Fermi Inc FRMI Surges 419 as Bulls Test Key Resistance at 72 APA Corporation Shows Modest Gains Trading Between Key Support and Resistance Levels Pinnacle Financial Partners PNFP Holds Near 97 Amid Narrow Trading Range UniFuels Holdings UFG Sheds 314 as Stock Tests Key Support Levels SoYoung International SY Plunges 165 Testing Key Support After Steep Decline Enterprise Products Partners EPD Slips 278 Key Support and Resistance Levels in Focus Janux Therapeutics JANX Rises 26 as Biotech Sentiment Improves